KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) FCF Margin (2016 - 2025)

Historic FCF Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 20.53%.

  • Biogen's FCF Margin fell 88600.0% to 20.53% in Q4 2025 from the same period last year, while for Dec 2025 it was 20.73%, marking a year-over-year decrease of 73900.0%. This contributed to the annual value of 20.73% for FY2025, which is 73900.0% down from last year.
  • Biogen's FCF Margin amounted to 20.53% in Q4 2025, which was down 88600.0% from 48.38% recorded in Q3 2025.
  • In the past 5 years, Biogen's FCF Margin ranged from a high of 48.38% in Q3 2025 and a low of 10.28% during Q4 2022
  • Over the past 5 years, Biogen's median FCF Margin value was 23.07% (recorded in 2022), while the average stood at 20.7%.
  • Per our database at Business Quant, Biogen's FCF Margin skyrocketed by 446600bps in 2021 and then crashed by -390500bps in 2022.
  • Biogen's FCF Margin (Quarter) stood at 28.78% in 2021, then crashed by -136bps to 10.28% in 2022, then skyrocketed by 79bps to 2.21% in 2023, then soared by 1431bps to 29.4% in 2024, then tumbled by -30bps to 20.53% in 2025.
  • Its FCF Margin was 20.53% in Q4 2025, compared to 48.38% in Q3 2025 and 5.08% in Q2 2025.